Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2001
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079291A2 Secreted proteins
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079256A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them
10/25/2001WO2001079206A1 Tricyclic quinazolinediones
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079179A2 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001079170A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/25/2001WO2001079164A2 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001079156A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001079155A2 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
10/25/2001WO2001078779A2 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078764A1 Treatment of hypertrophic cardiomyopathy with a substance that increases the level of growth hormone receptor antagonists
10/25/2001WO2001078757A2 Reversible immortalization
10/25/2001WO2001078755A2 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same
10/25/2001WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001WO2001078749A1 Novel calcium antagonists
10/25/2001WO2001078747A1 Use of cse inhibitors for treating heart failure
10/25/2001WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001WO2001078730A1 Methods and compositions useful in enhancing oxygen delivery to cells
10/25/2001WO2001078724A1 Rapid-onset formulation of a selective cyclooxigenase-2
10/25/2001WO2001078723A1 Compounds and methods
10/25/2001WO2001078718A1 Methods of use of penicillamines for the treatment of conditions resulting from dna damage
10/25/2001WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/25/2001WO2001078709A2 Treatment of neurodegenerative disease
10/25/2001WO2001078701A2 Method and compositions for preventing hormone induced adverse effects
10/25/2001WO2001078699A2 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
10/25/2001WO2001078688A1 Hydrophilic/lipophilic polymeric matrix dosage formulation
10/25/2001WO2001078649A2 Pharmaceutical curative compound
10/25/2001WO2001078529A2 Compositions and methods for improving vascular health
10/25/2001WO2001056596A8 Use of lysosomal acid lipase for treating atherosclerosis and related diseases
10/25/2001WO2001044246A8 Bicyclic inhibitors of glycogen synthase kinase 3
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001WO2001022976A3 Combination of a statin and ex-vivo treated blood for treating artheroclerosis
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001WO2000054761A9 Regulation of phospholipase d activity
10/25/2001US20010034371 Antidiabetic agents
10/25/2001US20010034370 Carnosic acid derivatives for promoting synthesis of nerve growth factor
10/25/2001US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001US20010034359 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
10/25/2001US20010034352 Cardiovascular disorders
10/25/2001US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001US20010034340 Hormone replacement therapy
10/25/2001US20010034337 Antiproliferative agents
10/25/2001US20010034334 Genetic engineered polypeptide
10/25/2001US20010034331 Isolated polypeptide
10/25/2001US20010034329 Nucleic acids
10/25/2001US20010034051 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
10/25/2001US20010033867 Systems and methods for local delivery of an agent
10/25/2001DE10019195A1 Gene complex for reversible cell immortalization, useful for expanding cells for cell replacement therapy of e.g. neurodegenerative disease, contains removable immortalizing gene
10/25/2001DE10019062A1 Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia
10/25/2001DE10018401A1 Medicament for treating hypertrophy-related myocardial disease, containing bradycardic agent, preferably cilobradine, and optionally another cardiac drug
10/25/2001CA2747325A1 Albumin fusion proteins
10/25/2001CA2575059A1 Pharmaceutical compositions comprising cilobradine
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2406378A1 Targeted vaccine delivery systems
10/25/2001CA2406226A1 Rapid-onset formulation of a selective cyclooxigenase-2
10/25/2001CA2406220A1 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001CA2406195A1 Lipid binding protein 4
10/25/2001CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001CA2406171A1 Reversible immortalization of cells
10/25/2001CA2406032A1 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase
10/25/2001CA2405781A1 Secreted proteins
10/25/2001CA2405709A1 Albumin fusion proteins
10/25/2001CA2405701A1 Albumin fusion proteins
10/25/2001CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001CA2405684A1 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
10/25/2001CA2405563A1 Albumin fusion proteins
10/25/2001CA2405557A1 Albumin fusion proteins
10/25/2001CA2405550A1 Albumin fusion proteins
10/25/2001CA2405525A1 Albumin fusion proteins
10/25/2001CA2405451A1 Molecules associated with human reproduction
10/25/2001CA2404858A1 Treatment of neurodegenerative disease
10/25/2001CA2404097A1 Method and compositions for preventing hormone induced adverse effects
10/25/2001CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/24/2001EP1148059A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
10/24/2001EP1148054A1 Thyroid receptor ligands
10/24/2001EP1147785A2 Therapeutic light source
10/24/2001EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001EP1147772A1 Medicinal compositions for treatment of atrial fibrillation
10/24/2001EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 1595